Vaclavikova et al. have determined the methylation status of the ABCB1 promoter in tumor tissues from 83 breast carcinoma patients prior to chemotherapy and 112 patients after chemotherapy (34 treated with 5-fluorouracil and mitomycin, 78 with doxorubicin) [139]. This evidence concerns the gene ABCB1 and breast carcinoma.